Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Meeting Summary - XYNTHA

MEMORANDUM

Date:
6-Jun-07
From:
Pauline Cottrell, DBA, HFM-380
RE:
Filing Meeting Summary for STN:125264/0
ATTENDEES:
Pauline Cottrell, Tim Lee, Nisha Jain, Paul Buehler, Iftekhar Mahmood, Boris Zaslavsky, Catherine Miller, Bhanu Kannan, Daniel Kearns
Sponsor:
Wyeth
Product:
Antihemophilic Factor (Recombinant), Plasma/Albumin Free
DUE DATE:
22-Feb-08
TO:
File

The SL indicated to me that STN: 125264/0 Antihemophilic Factor (Recombinant), Plasma/Albumin-free from Wyeth requesting CBER to eliminate the use of animal-and human-derived proteins resulting in the development of the ReFacto AF manufacturing process, may be filed. He may later request additional clarification of some of the information/data submitted.

Page Last Updated: 07/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.